These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 37164241)

  • 1. Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases.
    Homaeigohar S; Liu X; Elbahri M
    J Control Release; 2023 Jun; 358():476-497. PubMed ID: 37164241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
    Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonthermal Biocompatible Plasma Inactivation of Coronavirus SARS-CoV-2: Prospects for Future Antiviral Applications.
    Han I; Mumtaz S; Choi EH
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharides and Their Derivatives as Potential Antiviral Molecules.
    Claus-Desbonnet H; Nikly E; Nalbantova V; Karcheva-Bahchevanska D; Ivanova S; Pierre G; Benbassat N; Katsarov P; Michaud P; Lukova P; Delattre C
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.
    Chen X; Han W; Wang G; Zhao X
    Int J Biol Macromol; 2020 Dec; 164():331-343. PubMed ID: 32679328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-based approaches in the development of antiviral agents and vaccines.
    Li Y; Xiao Y; Chen Y; Huang K
    Life Sci; 2021 Jan; 265():118761. PubMed ID: 33189824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2.
    Imani SM; Ladouceur L; Marshall T; Maclachlan R; Soleymani L; Didar TF
    ACS Nano; 2020 Oct; 14(10):12341-12369. PubMed ID: 33034443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2.
    Manna S; Chowdhury T; Baindara P; Mandal SM
    Curr Protein Pept Sci; 2020; 21(10):938-947. PubMed ID: 32901582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Progress on Biomaterials Fighting against Viruses.
    Li S; Guo X; Gao R; Sun M; Xu L; Xu C; Kuang H
    Adv Mater; 2021 Apr; 33(14):e2005424. PubMed ID: 33644954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered nanomaterials as fighters against SARS-CoV-2: The way to control and treat pandemics.
    Abd Elkodous M; El-Sayyad GS; Abdel-Daim MM
    Environ Sci Pollut Res Int; 2021 Aug; 28(30):40409-40415. PubMed ID: 33068246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance antiviral nano-systems as a shield to inhibit viral infections: SARS-CoV-2 as a model case study.
    Sadique MA; Yadav S; Ranjan P; Verma S; Salammal ST; Khan MA; Kaushik A; Khan R
    J Mater Chem B; 2021 Jun; 9(23):4620-4642. PubMed ID: 34027540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Propolis on Viral Respiratory Diseases.
    Ożarowski M; Karpiński TM
    Molecules; 2023 Jan; 28(1):. PubMed ID: 36615554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Properties of Alginate-Based Biomaterials: Promising Antiviral Agents against SARS-CoV-2.
    Serrano-Aroca Á; Ferrandis-Montesinos M; Wang R
    ACS Appl Bio Mater; 2021 Aug; 4(8):5897-5907. PubMed ID: 35006918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses.
    Sheta SM; El-Sheikh SM
    Anal Biochem; 2022 Jul; 648():114680. PubMed ID: 35429447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Characterization of Advanced Materials: Use of Bacteriophage Phi 6 as Surrogate of Enveloped Viruses Such as SARS-CoV-2.
    Serrano-Aroca Á
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Cyanometabolites-A Review.
    Mazur-Marzec H; Cegłowska M; Konkel R; Pyrć K
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33810129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro.
    Yim SK; Kim K; Kim IH; Chun SH; Oh TH; Kim JU; Kim JW; Jung WH; Moon HS; Ku BS; Jung KJ
    Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoformulation-based Drug Delivery System for Viral Diseases.
    Bharti M; Alam MA; Koteswara Rao GSN; Sharma PK; Varshney S
    Pharm Nanotechnol; 2023; 11(2):105-126. PubMed ID: 36464883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.